世界の救命救急治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Critical Care Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1650 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、救命救急治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルブミン、プロトロンビン複合体濃縮物、アンチトロンビン濃縮物、第XIII因子濃縮物、フィブリノーゲン濃縮物）、用途別市場規模（肺塞栓症（PE）、急性冠症候群、心房細動、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・救命救急治療薬の市場動向 ・企業の競争状況、市場シェア ・救命救急治療薬の種類別市場規模（アルブミン、プロトロンビン複合体濃縮物、アンチトロンビン濃縮物、第XIII因子濃縮物、フィブリノーゲン濃縮物） ・救命救急治療薬の用途別市場規模（肺塞栓症（PE）、急性冠症候群、心房細動、その他） ・救命救急治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・救命救急治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・救命救急治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・救命救急治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・救命救急治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（CSL Behring、Grifols、Kedrion Biopharma、Octapharma、Takeda、Bayer HealthCare、Merck、Mitsubishi Tanabe Pharma、REVO Biologics、Rockwell Medical、Thermo Fisher Scientific、Shanghai RAAS、China Biologic Products、Cosmo Pharmaceuticals、King Pharmaceuticals） ・結論

Market Analysis and Insights: Global Critical Care Therapeutics Market
The global Critical Care Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Critical Care Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Critical Care Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Critical Care Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Critical Care Therapeutics market.

Global Critical Care Therapeutics Scope and Market Size
Critical Care Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Critical Care Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Albumin
Prothrombin Complex Concentrates
Antithrombin Concentrates
Factor XIII Concentrates
Fibrinogen Concentrates

Segment by Application
Pulmonary Embolism (PE)
Acute Coronary Syndrome
Atrial Fibrillation
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
CSL Behring
Grifols
Kedrion Biopharma
Octapharma
Takeda
Bayer HealthCare
Merck
Mitsubishi Tanabe Pharma
REVO Biologics
Octapharma
Takeda
Shanghai RAAS
China Biologic Products

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Critical Care Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Albumin
1.2.3 Prothrombin Complex Concentrates
1.2.4 Antithrombin Concentrates
1.2.5 Factor XIII Concentrates
1.2.6 Fibrinogen Concentrates
1.3 Market by Application
1.3.1 Global Critical Care Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pulmonary Embolism (PE)
1.3.3 Acute Coronary Syndrome
1.3.4 Atrial Fibrillation
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Critical Care Therapeutics Market Perspective (2016-2027)
2.2 Critical Care Therapeutics Growth Trends by Regions
2.2.1 Critical Care Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Critical Care Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Critical Care Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Critical Care Therapeutics Industry Dynamic
2.3.1 Critical Care Therapeutics Market Trends
2.3.2 Critical Care Therapeutics Market Drivers
2.3.3 Critical Care Therapeutics Market Challenges
2.3.4 Critical Care Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Critical Care Therapeutics Players by Revenue
3.1.1 Global Top Critical Care Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Critical Care Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Critical Care Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Critical Care Therapeutics Revenue
3.4 Global Critical Care Therapeutics Market Concentration Ratio
3.4.1 Global Critical Care Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Critical Care Therapeutics Revenue in 2020
3.5 Critical Care Therapeutics Key Players Head office and Area Served
3.6 Key Players Critical Care Therapeutics Product Solution and Service
3.7 Date of Enter into Critical Care Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Critical Care Therapeutics Breakdown Data by Type
4.1 Global Critical Care Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Critical Care Therapeutics Forecasted Market Size by Type (2022-2027)

5 Critical Care Therapeutics Breakdown Data by Application
5.1 Global Critical Care Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Critical Care Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Critical Care Therapeutics Market Size (2016-2027)
6.2 North America Critical Care Therapeutics Market Size by Type
6.2.1 North America Critical Care Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Critical Care Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Critical Care Therapeutics Market Size by Type (2016-2027)
6.3 North America Critical Care Therapeutics Market Size by Application
6.3.1 North America Critical Care Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Critical Care Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Critical Care Therapeutics Market Size by Application (2016-2027)
6.4 North America Critical Care Therapeutics Market Size by Country
6.4.1 North America Critical Care Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Critical Care Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Critical Care Therapeutics Market Size (2016-2027)
7.2 Europe Critical Care Therapeutics Market Size by Type
7.2.1 Europe Critical Care Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Critical Care Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Critical Care Therapeutics Market Size by Type (2016-2027)
7.3 Europe Critical Care Therapeutics Market Size by Application
7.3.1 Europe Critical Care Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Critical Care Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Critical Care Therapeutics Market Size by Application (2016-2027)
7.4 Europe Critical Care Therapeutics Market Size by Country
7.4.1 Europe Critical Care Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Critical Care Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Critical Care Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Critical Care Therapeutics Market Size by Type
8.2.1 Asia-Pacific Critical Care Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Critical Care Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Critical Care Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Critical Care Therapeutics Market Size by Application
8.3.1 Asia-Pacific Critical Care Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Critical Care Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Critical Care Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Critical Care Therapeutics Market Size by Region
8.4.1 Asia-Pacific Critical Care Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Critical Care Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Critical Care Therapeutics Market Size (2016-2027)
9.2 Latin America Critical Care Therapeutics Market Size by Type
9.2.1 Latin America Critical Care Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Critical Care Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Critical Care Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Critical Care Therapeutics Market Size by Application
9.3.1 Latin America Critical Care Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Critical Care Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Critical Care Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Critical Care Therapeutics Market Size by Country
9.4.1 Latin America Critical Care Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Critical Care Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Critical Care Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Critical Care Therapeutics Market Size by Type
10.2.1 Middle East & Africa Critical Care Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Critical Care Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Critical Care Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Critical Care Therapeutics Market Size by Application
10.3.1 Middle East & Africa Critical Care Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Critical Care Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Critical Care Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Critical Care Therapeutics Market Size by Country
10.4.1 Middle East & Africa Critical Care Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Critical Care Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Details
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Critical Care Therapeutics Introduction
11.1.4 CSL Behring Revenue in Critical Care Therapeutics Business (2016-2021)
11.1.5 CSL Behring Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Critical Care Therapeutics Introduction
11.2.4 Grifols Revenue in Critical Care Therapeutics Business (2016-2021)
11.2.5 Grifols Recent Development
11.3 Kedrion Biopharma
11.3.1 Kedrion Biopharma Company Details
11.3.2 Kedrion Biopharma Business Overview
11.3.3 Kedrion Biopharma Critical Care Therapeutics Introduction
11.3.4 Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2016-2021)
11.3.5 Kedrion Biopharma Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Critical Care Therapeutics Introduction
11.4.4 Octapharma Revenue in Critical Care Therapeutics Business (2016-2021)
11.4.5 Octapharma Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Critical Care Therapeutics Introduction
11.5.4 Takeda Revenue in Critical Care Therapeutics Business (2016-2021)
11.5.5 Takeda Recent Development
11.6 Bayer HealthCare
11.6.1 Bayer HealthCare Company Details
11.6.2 Bayer HealthCare Business Overview
11.6.3 Bayer HealthCare Critical Care Therapeutics Introduction
11.6.4 Bayer HealthCare Revenue in Critical Care Therapeutics Business (2016-2021)
11.6.5 Bayer HealthCare Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Critical Care Therapeutics Introduction
11.7.4 Merck Revenue in Critical Care Therapeutics Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Mitsubishi Tanabe Pharma
11.8.1 Mitsubishi Tanabe Pharma Company Details
11.8.2 Mitsubishi Tanabe Pharma Business Overview
11.8.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Introduction
11.8.4 Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2016-2021)
11.8.5 Mitsubishi Tanabe Pharma Recent Development
11.9 REVO Biologics
11.9.1 REVO Biologics Company Details
11.9.2 REVO Biologics Business Overview
11.9.3 REVO Biologics Critical Care Therapeutics Introduction
11.9.4 REVO Biologics Revenue in Critical Care Therapeutics Business (2016-2021)
11.9.5 REVO Biologics Recent Development
11.10 Rockwell Medical
11.10.1 Rockwell Medical Company Details
11.10.2 Rockwell Medical Business Overview
11.10.3 Rockwell Medical Critical Care Therapeutics Introduction
11.10.4 Rockwell Medical Revenue in Critical Care Therapeutics Business (2016-2021)
11.10.5 Rockwell Medical Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Critical Care Therapeutics Introduction
11.11.4 Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2016-2021)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Shanghai RAAS
11.12.1 Shanghai RAAS Company Details
11.12.2 Shanghai RAAS Business Overview
11.12.3 Shanghai RAAS Critical Care Therapeutics Introduction
11.12.4 Shanghai RAAS Revenue in Critical Care Therapeutics Business (2016-2021)
11.12.5 Shanghai RAAS Recent Development
11.13 China Biologic Products
11.13.1 China Biologic Products Company Details
11.13.2 China Biologic Products Business Overview
11.13.3 China Biologic Products Critical Care Therapeutics Introduction
11.13.4 China Biologic Products Revenue in Critical Care Therapeutics Business (2016-2021)
11.13.5 China Biologic Products Recent Development
11.14 Cosmo Pharmaceuticals
11.14.1 Cosmo Pharmaceuticals Company Details
11.14.2 Cosmo Pharmaceuticals Business Overview
11.14.3 Cosmo Pharmaceuticals Critical Care Therapeutics Introduction
11.14.4 Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2016-2021)
11.14.5 Cosmo Pharmaceuticals Recent Development
11.15 King Pharmaceuticals
11.15.1 King Pharmaceuticals Company Details
11.15.2 King Pharmaceuticals Business Overview
11.15.3 King Pharmaceuticals Critical Care Therapeutics Introduction
11.15.4 King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2016-2021)
11.15.5 King Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Critical Care Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Albumin
Table 3. Key Players of Prothrombin Complex Concentrates
Table 4. Key Players of Antithrombin Concentrates
Table 5. Key Players of Factor XIII Concentrates
Table 6. Key Players of Fibrinogen Concentrates
Table 7. Global Critical Care Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Critical Care Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Critical Care Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Critical Care Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Critical Care Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Critical Care Therapeutics Market Share by Regions (2022-2027)
Table 13. Critical Care Therapeutics Market Trends
Table 14. Critical Care Therapeutics Market Drivers
Table 15. Critical Care Therapeutics Market Challenges
Table 16. Critical Care Therapeutics Market Restraints
Table 17. Global Critical Care Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Critical Care Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Critical Care Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Critical Care Therapeutics as of 2020)
Table 20. Ranking of Global Top Critical Care Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Critical Care Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Critical Care Therapeutics Product Solution and Service
Table 24. Date of Enter into Critical Care Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Critical Care Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Critical Care Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Critical Care Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Critical Care Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Critical Care Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Critical Care Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Critical Care Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Critical Care Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Critical Care Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Critical Care Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Critical Care Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Critical Care Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Critical Care Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Critical Care Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Critical Care Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Critical Care Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Critical Care Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Critical Care Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Critical Care Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Critical Care Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Critical Care Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Critical Care Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Critical Care Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Critical Care Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Critical Care Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Critical Care Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Critical Care Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Critical Care Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Critical Care Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Critical Care Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Critical Care Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Critical Care Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Critical Care Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Critical Care Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Critical Care Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Critical Care Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Critical Care Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Critical Care Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. CSL Behring Company Details
Table 65. CSL Behring Business Overview
Table 66. CSL Behring Critical Care Therapeutics Product
Table 67. CSL Behring Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 68. CSL Behring Recent Development
Table 69. Grifols Company Details
Table 70. Grifols Business Overview
Table 71. Grifols Critical Care Therapeutics Product
Table 72. Grifols Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Grifols Recent Development
Table 74. Kedrion Biopharma Company Details
Table 75. Kedrion Biopharma Business Overview
Table 76. Kedrion Biopharma Critical Care Therapeutics Product
Table 77. Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Kedrion Biopharma Recent Development
Table 79. Octapharma Company Details
Table 80. Octapharma Business Overview
Table 81. Octapharma Critical Care Therapeutics Product
Table 82. Octapharma Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Octapharma Recent Development
Table 84. Takeda Company Details
Table 85. Takeda Business Overview
Table 86. Takeda Critical Care Therapeutics Product
Table 87. Takeda Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Takeda Recent Development
Table 89. Bayer HealthCare Company Details
Table 90. Bayer HealthCare Business Overview
Table 91. Bayer HealthCare Critical Care Therapeutics Product
Table 92. Bayer HealthCare Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Bayer HealthCare Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Critical Care Therapeutics Product
Table 97. Merck Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Mitsubishi Tanabe Pharma Company Details
Table 100. Mitsubishi Tanabe Pharma Business Overview
Table 101. Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Mitsubishi Tanabe Pharma Recent Development
Table 103. REVO Biologics Company Details
Table 104. REVO Biologics Business Overview
Table 105. REVO Biologics Critical Care Therapeutics Product
Table 106. REVO Biologics Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 107. REVO Biologics Recent Development
Table 108. Rockwell Medical Company Details
Table 109. Rockwell Medical Business Overview
Table 110. Rockwell Medical Critical Care Therapeutics Product
Table 111. Rockwell Medical Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Rockwell Medical Recent Development
Table 113. Thermo Fisher Scientific Company Details
Table 114. Thermo Fisher Scientific Business Overview
Table 115. Thermo Fisher Scientific Critical Care Therapeutics Product
Table 116. Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Thermo Fisher Scientific Recent Development
Table 118. Shanghai RAAS Company Details
Table 119. Shanghai RAAS Business Overview
Table 120. Shanghai RAAS Critical Care Therapeutics Product
Table 121. Shanghai RAAS Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 122. Shanghai RAAS Recent Development
Table 123. China Biologic Products Company Details
Table 124. China Biologic Products Business Overview
Table 125. China Biologic Products Critical Care Therapeutics Product
Table 126. China Biologic Products Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 127. China Biologic Products Recent Development
Table 128. Cosmo Pharmaceuticals Company Details
Table 129. Cosmo Pharmaceuticals Business Overview
Table 130. Cosmo Pharmaceuticals Critical Care Therapeutics Product
Table 131. Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 132. Cosmo Pharmaceuticals Recent Development
Table 133. King Pharmaceuticals Company Details
Table 134. King Pharmaceuticals Business Overview
Table 135. King Pharmaceuticals Critical Care Therapeutics Product
Table 136. King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2016-2021) & (US$ Million)
Table 137. King Pharmaceuticals Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Critical Care Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Albumin Features
Figure 3. Prothrombin Complex Concentrates Features
Figure 4. Antithrombin Concentrates Features
Figure 5. Factor XIII Concentrates Features
Figure 6. Fibrinogen Concentrates Features
Figure 7. Global Critical Care Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Pulmonary Embolism (PE) Case Studies
Figure 9. Acute Coronary Syndrome Case Studies
Figure 10. Atrial Fibrillation Case Studies
Figure 11. Other Case Studies
Figure 12. Critical Care Therapeutics Report Years Considered
Figure 13. Global Critical Care Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Critical Care Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Critical Care Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Critical Care Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Critical Care Therapeutics Market Share by Players in 2020
Figure 18. Global Top Critical Care Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Critical Care Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Critical Care Therapeutics Revenue in 2020
Figure 20. Global Critical Care Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Critical Care Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Critical Care Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Critical Care Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Critical Care Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Critical Care Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Critical Care Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Critical Care Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Critical Care Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Critical Care Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Critical Care Therapeutics Market Share by Region (2016-2027)
Figure 42. China Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Critical Care Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Critical Care Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Critical Care Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Critical Care Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Critical Care Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Critical Care Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Critical Care Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. CSL Behring Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 62. Grifols Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 63. Kedrion Biopharma Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 64. Octapharma Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 65. Takeda Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 66. Bayer HealthCare Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 68. Mitsubishi Tanabe Pharma Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 69. REVO Biologics Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 70. Rockwell Medical Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 72. Shanghai RAAS Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 73. China Biologic Products Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 74. Cosmo Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 75. King Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

---